Rockwell Medical (RMTI) EBIT Margin (2010 - 2026)

Rockwell Medical has reported EBIT Margin for 17 years, with the latest figure at 8.54% in Q1 2026.

• For the quarter ending Q1 2026, EBIT Margin fell 135.0% year-over-year to 8.54%; the trailing twelve-month figure through Mar 2026 stood at 7.11% (down 769.0% YoY), and the FY2025 full-year result was 6.77%, down 737.0% from the prior year.
• EBIT Margin for Q1 2026 stood at 8.54%, down from 2.17% in the prior quarter.
• The five-year high for EBIT Margin was 6.84% in Q3 2024, with the low at 41.09% in Q1 2022.
• Historically, EBIT Margin has averaged 9.64% across 5 years, with a median of 7.31% in 2023.
• Annual changes were most pronounced in 2022 — EBIT Margin jumped 4434 bps — and 2025, when it sank 1678 bps.
• Rockwell Medical's EBIT Margin stood at 10.18% in 2022, then surged by 76 bps to 2.48% in 2023, then gained by 15 bps to 2.1% in 2024, then decreased by 3 bps to 2.17% in 2025, then plunged by 294 bps to 8.54% in 2026.
• The last three EBIT Margin figures came in at 8.54% (Q1 2026), 2.17% (Q4 2025), and 9.95% (Q3 2025), per Business Quant data.